AI assistant
Sending…
Pyxis Oncology, Inc. — Director's Dealing 2023
Sep 19, 2023
33976_dirs_2023-09-18_45b81ec0-fa58-4139-afc7-6a10dd652c41.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pyxis Oncology, Inc. (PYXS)
CIK: 0001782223
Period of Report: 2023-09-14
Reporting Person: Sullivan Lara (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-09-14 | Common Stock | S | 100 | $2.25 | Disposed | 2412423 | Direct |
| 2023-09-18 | Common Stock | S | 8541 | $2.10 | Disposed | 2403882 | Direct |
More from Pyxis Oncology, Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Regulatory Filings
2026
Apr 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25
Annual Report
2026
Mar 23
Regulatory Filings
2026
Mar 23